New NIH R01 Funded

April 2, 2019 by   |   Leave a Comment

Associate Elizabeth (Beth) Sharlow, Associate Director of the Fiske Drug Discovery Laboratory, has just received a $1.2 million R01 grant from the NIH to develop a precision high content screening assay for Abeta-mediated neuronal cell cycle re-entry. This grant builds on funding to the Fiske Drug Discovery Laboratory from the Cure Alzheimer’s Fund and the Owen Family Foundation.



Leave a Reply

Your email address will not be published. Required fields are marked *